Endocrine Society GUIDELINES Bundle (free trial)

Obesity

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140184

Contents of this Issue

Navigation

Page 5 of 11

Treatment Table 3. Drugs Associated with Weight Gain and Suggested Alternatives (Where evidence is mixed or reports are of a few cases, a "?" has been added.) Category Drug Class Weight Gain Alternatives – weight reducing in parentheses Psychiatric Agents Antipsychotic • Clozapine • Risperidone • Olanzapine • Quetiapine • Haloperidol • Perphenazine • Ziprasidone • Aripiprazole Antidepressants/ mood stabilizers: tricyclic antidepressants • Amitriptyline • Doxepin • Imipramine • Nortriptyline • Trimipramine • Mirtazapine • (Bupropion) • Nefazodone • Fluoxetine (short term) • Sertraline (<1 yr) Antidepressants/ mood stabilizers: SSRIs • Fluoxetine? • Sertraline? • Paroxetine • Fluvoxamine Antidepressants/ mood stabilizers: MAO inhibitors • Phenelzine • Tranylcypromine Lithium • N/A Neurologic Agents Anticonvulsants • Carbamazepine • Gabapentin • Valproate • Lamotrigine? • (Topiramate) • (Zonisamide) Endocrinologic Agents Diabetes drugs • Insulin (weight gain differs with type and regimen used) • Sulfonylureas • Thiazolidinediones • Sitagliptin? • Mitiglinide • (Metformin) • (Acarbose) • (Miglitol) • (Pramlintide) • (Exenatide) • (Liraglutide) Gynecologic Agents Oral contraceptives • Progestational steroids • Hormonal contraceptives containing progestational steroids • Barrier methods • IUDs Endometriosis treatment • Depot leuprolide acetate • Surgical methods

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Obesity